A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia
Status:
Recruiting
Trial end date:
2020-07-01
Target enrollment:
Participant gender:
Summary
Based on oseltamivir treatment, evaluate the efficacy and safety of ASC09/ritonavir compound
tablets(ASC09F) or ritonavir tablets for 2019-nCoV infection patients.